Foghorn Therapeutics Inc. (FHTX) Financials
FHTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 285.9 million | 363.1 million |
2023-09-30 | 313.4 million | 370.8 million |
2023-06-30 | 339.6 million | 388.9 million |
2023-03-31 | 372.9 million | 397.5 million |
FHTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -27.6 million | 3.1 million |
2023-09-30 | -27.3 million | 4.1 million |
2023-06-30 | -32.6 million | 4.5 million |
2023-03-31 | -31.8 million | 4.6 million |
FHTX Net Income
No data available :(
FHTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 234.1 million | - | 45.1 million |
2023-09-30 | 259.9 million | - | 47.1 million |
2023-06-30 | 284.3 million | - | 47.9 million |
2023-03-31 | 316.0 million | - | 49.8 million |
FHTX Shares Outstanding
FHTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 37000 | 23.4 million | 7.0 million | - |
2023-09-30 | 82000 | 26.3 million | 8.3 million | - |
2023-06-30 | 469000 | 29.2 million | 8.4 million | - |
2023-03-31 | 636000 | 30.0 million | 8.6 million | - |
FHTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 5.8 million | 852000 |
2023-09-30 | 17.5 million | 864000 |
2023-06-30 | 5.6 million | 2.2 million |
2023-03-31 | 5.3 million | 2.1 million |
FHTX
Price: $5.90
52 week price:
Earnings Per Share: -2.34 USD
P/E Ratio: -2.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 18512
Market Capitalization: 306.9 million